Ipsen SA to acquire Clementia Pharmaceuticals Conference Call Transcript
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to today's Ipsen's conference call. (Operator Instructions) I must advise you that this conference is being recorded today, Monday, 25 February 2019.
I would now like to hand the conference over to your speaker today, David Meek. Please got ahead.
Good afternoon and good morning, and thank you for joining us today to discuss Ipsen's acquisition of Clementia Pharmaceuticals. With me on the call for the Q&A session are Aymeric Le Chatelier, our CFO; Dr. Alex Lebeaut, our CSO; and Harout Semerjian, our Chief Commercial Officer.
Before we begin, I would like to thank our colleagues at Clementia for their strong collaboration and team spirit. We very much look forward to working closely with them to ensure a smooth transition and integration. Here is our safe harbor statement that outlines the routine risks and uncertainties combined within this presentation.
We are very pleased to announce today the acquisition
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
